Poland· PL-100196030
Dicloratio
A diclofenac product containing diclofenacum natricum + lidocaini hydrochloridum monohydricum, registered in Poland by ratiopharm GmbH. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Diclofenac is registered in 16 of 19 countries.
Countries holding a registration under ATC M01AB05 (diclofenac), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Diclofenac · ATC M01AB05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of diclofenac costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.26 in Italy to $1.11 in Switzerland — a ×4.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Diclofenac · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.11
- IT Italy$0.26
The record
At a glance
URPL (Poland)- Active substance
- Diclofenacum natricum + Lidocaini hydrochloridum monohydricum
- Manufacturer
- ratiopharm GmbH
- Country
- Poland (PL)
- ATC code
- M01AB05
- ATC class
- Diclofenac
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- June 7, 2026
Packs & prices · 3
- gtin05909990413812
- gtin05909990413836
- gtin05909990413829
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
841 interactions on record for diclofenac.
Graded by severity as the source publishes them — 68 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Diclofenac · interactions on record
841 records
- 68 severe
- 331 moderate
- 17 minor
- 340 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
85 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Diclofenac in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDiclonaClinic Pharma
- SwitzerlandDiclo-Acino 75, Injektionslösung i.m.Acino Pharma AG
- GermanyDiclofenac RatiopharmRatiopharm Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Diclofenac Ratiopharm
- Lithuania · Olfen
- Luxembourg · Diclofenac Ratiopharm®
- Latvia · Olfen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9185d3d6-c5be-4978-88c0-58663a8e5996 GET /v1/drugs/9185d3d6-c5be-4978-88c0-58663a8e5996?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "(75 mg + 20 mg)/2 ml",
"packaging": "05909990413812 ¦ Rp ¦ Skasowane ¦ 13059\n1 amp. 2 ml\n05909990413836 ¦ Rp ¦ 13060\n30 amp. 2 ml\n05909990413829 ¦ Rp ¦ 47916\n3 amp. 2 ml",
"substance": "Diclofenacum natricum 75 mg/2 ml + Lidocaini hydrochloridum monohydricum 20 mg/2 ml",
"common_name": "Diclofenacum natricum + Lidocaini hydrochloridum monohydricum",
"pl_product_id": "100196030",
"pozwolenie_nr": "04138",
"auth_procedure": "NAR",
"authorisation_validity": "2023-06-12"
}See everything about diclofenac.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.